1. Binkowski B, Fan F, Wood K. Engineered luciferases for molecular sensing in living cells. Curr Opin Biotechnol. 2009;20(1):14-8. [
Link] [
DOI:10.1016/j.copbio.2009.02.013]
2. Wang L, Fu Q, Dong Y, Zhou Y, Jia Sh, Du J, et al. Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals. Antivir Res. 2010;87(1):50-6. [
Link] [
DOI:10.1016/j.antiviral.2010.04.010]
3. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol. 2007;5(6):453-63. [
Link] [
DOI:10.1038/nrmicro1645]
4. Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol. 2009;50(3):453-60. [
Link] [
DOI:10.1016/j.jhep.2008.06.010]
5. Pockros PJ. New direct-acting antivirals in the development for hepatitis C virus infection. Ther Adv Gastroenterol. 2010;3(3):191-202. [
Link] [
DOI:10.1177/1756283X10363055]
6. Mortazavi M, Hosseinkhani S. Design of thermostable luciferases through arginine saturation in solvent-exposed loops. Protein Eng Des Sel. 2011;24(12):893-903. [
Link] [
DOI:10.1093/protein/gzr051]
7. Kozomara A, Griffiths-Jones S. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2010;39(suppl-1):D152-7. [
Link] [
DOI:10.1093/nar/gkq1027]
8. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327(5962):198-201. [
Link] [
DOI:10.1126/science.1178178]
9. Deiters A. Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J. 2010;12(1):51-60. [
Link] [
DOI:10.1208/s12248-009-9159-3]
10. Li L, Xu J, Yang D, Tan X, Wang H. Computational approaches for microRNA studies: A review. Mamm Genome. 2010;21(1-2):1-12. [
Link] [
DOI:10.1007/s00335-009-9241-2]
11. Shrivastava Sh, Steele R, Ray R, Ray RB. MicroRNAs: Role in hepatitis C virus pathogenesis. Genes Dis. 2015;2(1):35-45. [
Link] [
DOI:10.1016/j.gendis.2015.01.001]
12. Connelly CM, Thomas M, Deiters A. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J Biomol Screen. 2012;17(6):822-8. [
Link] [
DOI:10.1177/1087057112439606]
13. vita.mbc.nctu.edu.tw [Internet]. Hsinchu: National Chiao Tung University; 2006 [cited 2017 July 9]. Available from: http://vita.mbc.nctu.edu.tw [
Link]
14. Cheng JC, Yeh YJ, Tseng CP, Hsu SD, Chang YL, Sakamoto N, et al. Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci. 2012;69(15):2621-33. [
Link] [
DOI:10.1007/s00018-012-0940-6]
15. Rougvie AE. Control of developmental timing in animals. Nat Rev Genet. 2001;2(9):690-701. [
Link] [
DOI:10.1038/35088566]
16. Shafaati M, Jamalidoust M, Ziyaeyan M, Kargar M, Arefian E. Liver micro-RNAs and their role in different HCV genotype infections. Pathobiol Res. 2018;20(4):1-19. [Persian] [
Link]
17. Alipour BS, Hosseinkhani S, Ardestani SK, Moradi A. The effective role of positive charge saturation in bioluminescence color and thermostability of firefly luciferase. Photochem Photobiol Sci. 2009;8(6):847-55. [
Link] [
DOI:10.1039/b901938c]
18. Du J, Zhao F, Zhou Y, Yan H, Duan XG, Liang SQ, et al. Bioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in mice. PLoS One. 2010;5(11):e14043. [
Link] [
DOI:10.1371/journal.pone.0014043]
19. Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J. 2014;11(1):64. [
Link] [
DOI:10.1186/1743-422X-11-64]
20. Fukuhara T, Kambara H, Shiokawa M, Ono Ch, Katoh H, Morita E, et al. Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J Virol. 2012;86(15):7918-33. [
Link] [
DOI:10.1128/JVI.00567-12]
21. Wang H, Gao H, Duan Sh, Song X. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway. Virus Res. 2015;208:7-12. [
Link] [
DOI:10.1016/j.virusres.2015.05.002]
22. Houdebine LM. Design of vectors for optimizing transgene expression. In: Pinkert CA, editor. Transgenic animal technology. 3rd Edition. Amsterdam: Elsevier; 2014. pp. 489-511. [
Link] [
DOI:10.1016/B978-0-12-410490-7.00017-7]
23. Chan CH, Yu TH, Wong KB. Stabilizing salt-bridge enhances protein thermostability by reducing the heat capacity change of unfolding. PloS One. 2011;6(6):e21624. [
Link] [
DOI:10.1371/journal.pone.0021624]
24. Wilson JA, Zhang C, Huys A, Richardson CD. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol. 2011;85(5):2342-50. [
Link] [
DOI:10.1128/JVI.02046-10]